Skip to main content

The Dutch newspaper, Leidsch Dagblad, published an article on the TTW-grant that the Leiden University has received to collaborate with private partners ZoBio, and Batavia Biosciences to propel SATIRN® technology, developed by Batavia Biosciences. The project aims to deliver, amongst others, a better influenza vaccine by use of this membrane protein formulation technology.

Full article (in Dutch)